↓ Skip to main content

The Clinical Implications of Nocebo Effects for Biosimilar Therapy

Overview of attention for article published in Frontiers in Pharmacology, November 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
11 X users

Readers on

mendeley
127 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Clinical Implications of Nocebo Effects for Biosimilar Therapy
Published in
Frontiers in Pharmacology, November 2019
DOI 10.3389/fphar.2019.01372
Pubmed ID
Authors

Luana Colloca, Remo Panaccione, T. Kevin Murphy

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 127 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 13%
Student > Ph. D. Student 15 12%
Student > Bachelor 11 9%
Other 9 7%
Student > Master 8 6%
Other 20 16%
Unknown 47 37%
Readers by discipline Count As %
Medicine and Dentistry 22 17%
Nursing and Health Professions 12 9%
Pharmacology, Toxicology and Pharmaceutical Science 11 9%
Agricultural and Biological Sciences 5 4%
Neuroscience 5 4%
Other 25 20%
Unknown 47 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2020.
All research outputs
#5,763,624
of 23,577,761 outputs
Outputs from Frontiers in Pharmacology
#2,312
of 17,176 outputs
Outputs of similar age
#120,052
of 462,169 outputs
Outputs of similar age from Frontiers in Pharmacology
#70
of 337 outputs
Altmetric has tracked 23,577,761 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,176 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,169 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 337 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.